RELMADA THERAPEUTICS, INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
RELMADA THERAPEUTICS, INC. (RLMD) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 2.18% for the 9-month period ending 2018-03-31, per its 10-Q filed 2018-05-14.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-05-14
- RELMADA THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for the quarter ending 2017-09-30 was 1.47%.
- RELMADA THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 0.71%.
- RELMADA THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2013 was 0.38%, a 100.00% increase from fiscal 2012.
- RELMADA THERAPEUTICS, INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2012 was 0.19%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 3 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 6 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 9 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | 2.18% 10-Q · filed 2018-05-14 | |||
| 2017-12-31 | 1.83% 10-Q · filed 2018-02-12 | |||
| 2017-09-30 | 1.47% 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | 1.38% 10-Q · filed 2018-05-14 | |||
| 2016-06-30 | 0.71% 10-K · filed 2017-09-28 | |||
| 2014-06-30 | 1.60% 10-KT · filed 2014-09-09 | |||
| 2013-12-31 | 0.38% 10-KT · filed 2014-09-09 | |||
| 2012-12-31 | 0.19% 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |